1) having audited lower-income countries' factories, for a tiny bit years ago, convinced me that this is true of just about any country at a lower level of economic development. Rigorous regulatory enforcement is expensive, and poor countries are poor.
2) it is not just a problem with generic drugs in India, it is a problem with anything that is painted (lead?), anything with plastics in it, etc. etc.
3) it is interesting that the one case where Bloomberg seems to be saying "this outsourcing our manufacturing to the Third World is a problem", is the case where the industry in question has a profit-related reason to want it to stop. In most industries, the U.S. companies want to manufacture there, so that is "free trade", and I think Bloomberg would be in favor and unlikely to run a story like this.
2) it is not just a problem with generic drugs in India, it is a problem with anything that is painted (lead?), anything with plastics in it, etc. etc.
3) it is interesting that the one case where Bloomberg seems to be saying "this outsourcing our manufacturing to the Third World is a problem", is the case where the industry in question has a profit-related reason to want it to stop. In most industries, the U.S. companies want to manufacture there, so that is "free trade", and I think Bloomberg would be in favor and unlikely to run a story like this.